Athenex, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $102.8M | $95.4M | $46.9M | $25.3M | $89.1M | $38.0M |
| Operating income | −$70.0M | −$150.4M | −$15.6M | −$34.3M | −$126.8M | −$110.0M |
| Net income | −$103.4M | −$199.8M | −$19.4M | −$35.2M | −$117.4M | −$131.2M |
| Total assets | $204.1M | $267.4M | $384.3M | $309.9M | $231.1M | $140.4M |
| Total liabilities | $228.2M | $233.0M | $219.0M | $134.1M | $102.3M | $49.7M |
| Equity | −$6.5M | $51.1M | $179.8M | $188.2M | $139.4M | $90.0M |
| EPS (diluted) | $-15.81 | $-38.44 | — | — | — | — |
| Shares out. | 110.4M | 93.5M | 81.6M | 67.0M | 63.5M | 58.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −68.1%
- Net margin
- −100.6%
- Return on equity
- 1589.7%
- Return on assets
- −50.7%
- Return on capital (ROCE)
- −78.5%
- Liabilities / assets
- 111.9%
- Debt / equity
- —
- Book value / share
- $-0.06
- Revenue growth (YoY)
- 7.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -18.26distress
- Accruals / assets
- −19.2%clean
- Beneish M-Score
- -3.16normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 23, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Completed an acquisition or disposition · Modified shareholder rights · Director / officer changeOct 2, 2023
- Director / officer changeAug 17, 2023
- Entered a material agreement · Terminated a material agreement · Bankruptcy or receivership · Completed an acquisition or disposition · Director / officer changeJul 18, 2023
- Bankruptcy or receivership · Debt acceleration / triggering event · Costs from exit or disposal · Delisting / listing-standard notice · Director / officer changeMay 22, 2023
- Delisting / listing-standard noticeMay 3, 2023
- Director / officer changeApr 25, 2023
- Amended charter or bylawsMar 31, 2023
- Results of operationsMar 20, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13D/AOct 18, 2023
- 8-KOct 2, 2023
- 8-KAug 17, 2023
- 8-KJul 18, 2023
- 25-NSEJul 10, 2023
- NT 10-QMay 23, 2023
- 8-KMay 22, 2023
- 4FORM 4 SUBMISSIONMay 8, 2023
- 4FORM 4 SUBMISSIONMay 8, 2023
- 4FORM 4 SUBMISSIONMay 8, 2023
- 8-KMay 3, 2023
- 10-K/AApr 28, 2023
- 8-KApr 25, 2023
- 4FORM 4 SUBMISSIONApr 24, 2023
- 4FORM 4 SUBMISSIONApr 24, 2023